[CRMD] CorMedix Inc

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: AMEX

The data is delayed by 15 minutes.

 

Price: 1.75 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart CRMD

Refresh chart

Strongest Trends Summary For CRMD

CRMD is in the long-term up 2680% in 2 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: CorMedix Inc., a development-stage pharmaceutical and medical device company, intends to in-license, develop, and commercialize therapeutic products for the treatment of cardiorenal and infectious diseases. The company?s product candidates include CRMD003 (Neutrolin) and CRMD004, an antimicrobial/antifungal and anticoagulant combination in liquid and gel formulations used for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -22.5% Sales Growth - Q/Q-63.53% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-94.73% ROE-121.62% ROI
Current Ratio4.57 Quick Ratio4.35 Long Term Debt/Equity Debt Ratio0.28
Gross Margin-83.65% Operating Margin-5512.02% Net Profit Margin-4441.35% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities6.83 M Cash From Investing Activities-10 K Cash From Operating Activities-2.35 M Gross Profit10 K
Net Profit-5.5 M Operating Profit-5.5 M Total Assets9.75 M Total Current Assets9.69 M
Total Current Liabilities2.12 M Total Debt Total Liabilities2.16 M Total Revenue30 K
Technical Data
High 52 week13.25 Low 52 week0.21 Last close8.2 Last change-2.26%
RSI37.07 Average true range0.49 Beta0.7 Volume213.35 K
Simple moving average 20 days-7.81% Simple moving average 50 days-1.14% Simple moving average 200 days27.2%
Performance Data
Performance Week-11.35% Performance Month-12.49% Performance Quart11.41% Performance Half-16.75%
Performance Year2546.87% Performance Year-to-date535.66% Volatility daily3.36% Volatility weekly7.52%
Volatility monthly15.41% Volatility yearly53.4% Relative Volume420.72% Average Volume408.2 K
New High New Low

News

2019-11-15 05:12:20 | Edited Transcript of CRMD earnings conference call or presentation 14-Nov-19 9:30pm GMT

2019-11-14 17:35:10 | CorMedix CRMD Reports Q3 Loss, Misses Revenue Estimates

2019-11-14 16:05:00 | CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update

2019-11-07 08:00:00 | CorMedix Inc. to Report Third Quarter 2019 Financial Results and Provide a Corporate Update on November 14

2019-11-06 10:30:03 | CorMedix CRMD May Report Negative Earnings: Know the Trend Ahead of Q3 Release

2019-11-06 08:15:00 | CorMedix Inc. Announces a Change to its Senior Leadership

2019-10-24 07:55:22 | Have Insiders Been Buying CorMedix, Inc. NYSEMKT:CRMD Shares This Year?

2019-10-16 08:15:00 | CorMedix Completes Successful CMC Interaction with the FDA

2019-09-26 16:30:00 | CorMedix Inc. to Present at the Cantor 2019 Global Healthcare Conference

2019-09-26 08:15:00 | CorMedix Inc. Announces Exercises of Outstanding Warrants

2019-09-24 19:14:01 | Biggest Hedge Fund Buys of September

2019-09-18 10:17:01 | Should You Worry About CorMedix, Inc.'s NYSEMKT:CRMD CEO Pay?

2019-09-03 16:30:00 | CorMedix Inc. to Present at the H.C. Wainwright 21st Annual Global Investment Conference

2019-08-14 19:21:53 | CorMedix Inc. Announces Exchange Agreement With Its Largest Investor

2019-08-14 15:49:54 | Edited Transcript of CRMD earnings conference call or presentation 13-Aug-19 8:30pm GMT

2019-08-13 17:45:09 | CorMedix CRMD Reports Q2 Loss, Misses Revenue Estimates

2019-08-13 16:05:00 | CorMedix Inc. Reports Second Quarter and Six Month 2019 Financial Results and Provides Business Update

2019-08-13 13:47:22 | Is CorMedix NYSEMKT:CRMD Weighed On By Its Debt Load?

2019-08-06 10:30:02 | CorMedix CRMD May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-08-01 08:30:00 | CorMedix Inc. to Report Second Quarter 2019 Financial Results and Provide a Corporate Update on August 13

2019-07-31 11:28:05 | 7 A-Rated Stocks Under $10

2019-07-17 08:15:00 | CorMedix Presents at FDA Public Meeting on the Limited Population Pathway for Antibacterial and Antifungal Drugs

2019-07-09 11:42:54 | Why CorMedix Shares Are Rallying

2019-07-09 08:15:00 | CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data

2019-07-08 08:30:00 | CorMedix Announces Publication of Taurolidine Pre-Clinical Oncology Data in “Investigational New Drugs” Journal

2019-06-28 14:19:40 | 18 Stocks Joining The Russell Indices

2019-06-26 08:30:00 | CorMedix Inc. Set to Join the Russell 2000® Index

2019-06-10 08:30:00 | CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10

2019-05-16 08:45:00 | CorMedix Inc. to Present at the 20th Annual B. Riley FBR Institutional Investor Conference

2019-05-13 22:28:56 | Edited Transcript of CRMD earnings conference call or presentation 13-May-19 8:30pm GMT

2019-05-13 17:45:09 | CorMedix CRMD Reports Q1 Loss, Tops Revenue Estimates

2019-05-13 16:41:01 | CorMedix: 1Q Earnings Snapshot

2019-05-13 16:05:00 | CorMedix Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

2019-05-10 08:15:00 | Cormedix Announces Presentation of LOCK-IT-100 Study Results at National Kidney Foundation Spring 2019 Meeting

2019-05-08 09:07:01 | Should You Take Comfort From Insider Transactions At CorMedix, Inc. NYSEMKT:CRMD?

2019-05-06 08:15:00 | CorMedix Inc. to Report First Quarter 2019 Financial Results and Provide a Corporate Update on May 13

2019-04-22 08:15:00 | CorMedix Announces Online Pre-Clinical Abstract at the Upcoming Annual Meeting of American Society of Clinical Oncology

2019-04-17 08:00:00 | CorMedix Completes Sale of $5.4 Million of NOL Tax Benefits Through New Jersey Economic Development Authority Program

2019-04-11 16:15:00 | CorMedix Notified of Compliance with NYSE American Listing Requirements

2019-04-02 08:05:54 | Is CorMedix, Inc. NYSEMKT:CRMD Overpaying Its CEO?

2019-03-26 07:36:32 | The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs

2019-03-25 16:15:00 | CorMedix Confirms Previously Announced One-For-Five Reverse Stock Split

2019-03-21 08:30:00 | CorMedix Inc. Announces Appointment of Phoebe Mounts as Executive Vice President and General Counsel

2019-03-14 16:05:00 | CorMedix Inc. Reports Fourth Quarter And Full-Year 2018 Financial Results, Announces Reverse Stock Split And Provides Business Update

2019-03-11 16:35:00 | CorMedix Inc. to Present at Roth and Oppenheimer & Co. Investor Conferences

2019-03-11 10:30:02 | Will CorMedix CRMD Report Negative Q4 Earnings? What You Should Know

2019-03-07 08:00:00 | CorMedix Inc. to Report Year Ended December 31, 2018 Financial Results on Thursday, March 14

2019-03-04 08:00:00 | CorMedix Inc. Appoints Alan W. Dunton, M.D. to Board of Directors

2019-02-21 07:20:00 | Research Report Identifies SS&C Technologies, Allergan plc, CorMedix, The Allstate, Vedanta, and Lexicon Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2019-02-20 08:00:00 | Biotech Bounce Just Getting Started